AI in Healthcare and Life Sciences: Accelerating Drug Development in a Rapidly Evolving Technical Landscape

Presentation by Caroline Phares, Vice President, Healthcare & Life Sciences at Altair and Matt Jones, Founder and CEO of Veramed as part of Altair's Future.Industry 2025 conference.

As artificial intelligence reshapes industries worldwide, the healthcare and life sciences industries are poised for revolutionary breakthroughs. We have seen investments being made in applying AI to areas such as diagnostics, target identification, and molecule discovery. However, in drug development, in particular clinical trials, the pharmaceutical industry has struggled to successfully implement new technologies to accelerate. This session explores the challenges and solutions to truly unleashing power of AI in clinical development. Additionally, some new initiatives to aid the industry in properly applying the available technology will be revealed and discussed.